Actinium Pharmaceuticals Inc (ATNM) has fallen 0.61% Wednesday In Premarket Trading

Actinium Pharmaceuticals Inc (ATNM) is lower by Wednesday morning, with the stock losing -0.61% in pre-market trading to 8.16. ATNM's short-term technical score of 74 indicates that the stock has traded more bullishly over the last month than 74% of stocks on the market. In the Biotechnology industry, which ranks 102 out of 146 industries, the stock ranks higher than 86% of stocks. Actinium Pharmaceuticals Inc has risen 28.89% over the past month, closing at $6.66 on February 21. During this period of time, the stock fell as low as $6.27 and as high as $8.78. ATNM has an average analyst recommendation of Strong Buy. The company has an average price target of $23.72.

ATNM has an Overall Score of 71. Find out what this means to you and get the rest of the rankings on ATNM!

See Full ATNM Report

Actinium Pharmaceuticals Inc has a Long-Term Technical rank of 60. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 40% of the market scoring higher. In the Biotechnology industry which is number 67 by this metric, ATNM ranks better than 67% of stocks.

Important Dates for Investors in ATNM:

-Actinium Pharmaceuticals Inc is set to release earnings on 2024-04-01. Over the last 12 months, the company has reported EPS of $-1.92. -We do not have a set dividend date for Actinium Pharmaceuticals Inc at this time. Click Here To Get The Full Report on Actinium Pharmaceuticals Inc (ATNM)